Table 3. Performance comparison of the proposed MSRNet with other models in AD and NC classification based on inter-database cross-validation with the ADNI, AIBL, EDSD, and OASIS databases.
Method | ACC (%) | SEN (%) | SPE (%) | AUC (%) |
---|---|---|---|---|
AGNN | 85.2 | 65.6 | 92.8 | 89.7 |
GAT | 84.0 | 61.9 | 92.6 | 88.5 |
GraphSAGE | 87.3 | 72.9 | 92.9 | 91.7 |
HGNN | 77.5 | 35.8 | 93.9 | 72.7 |
Graph U-Net | 77.7 | 29.5 | 96.5 | 71.1 |
ConvMixer | 86.2 | 78.1 | 88.8 | 91.1 |
3D VGG-16 | 88.8 | 79.2 | 91.4 | 94.6 |
3DAN | 88.3 | 73.1 | 94.2 | 91.7 |
Proposed MSRNet | 90.6 | 82.0 | 93.6 | 93.9 |
AD, Alzheimer’s disease; NC, normal control; ACC, accuracy; SEN, sensitivity; SPE, specificity; AUC, area under the curve; MSRNet, multispatial information representation model; ADNI, Alzheimer’s Disease Neuroimaging Initiative database; AIBL, Australian Imaging Biomarkers and Lifestyle; EDSD, European DTI Study on Dementia database; OASIS, Open Access Series of Imaging Studies; DTI, diffusion tensor imaging; AGNN, attention-based graph neural network; GAT, graph attention network; HGNN, hypergraph neural network; 3D VGG-16, 3D visual geometry group 16; 3DAN, 3D attention network.